Navigation Links
BioXcel Launches Its Flagship Product, PharmGPS™
Date:4/22/2013

Branford, CT (PRWEB) April 22, 2013

BioXcel Corporation, coinciding with the BIO International 2013 Convention in Chicago, announced the launch of PharmGPS™, a “first-in-class,” dynamic analytics platform with customizable apps, built to address complex investment decisions across the biopharmaceutical industry stakeholder value-chain.

“Decision making and knowledge management paradigms are fragmented and becoming increasingly complex with the explosion of data and a rapidly evolving healthcare ecosystem,” said Dr. Vimal Mehta, BioXcel’s Chairman. “PharmGPS™ provides an innovative solution to revolutionize decision making with a unified platform for actionable decisions thereby optimizing investments and enhancing the probability of success.

PharmGPS™ is a disease-area focused, analytics engine encompassing all major and specialty therapeutic areas. Using a patient-centric approach, PharmGPS™ assesses each disease indication for the best window of commercial opportunity, dynamic probability of technical and regulatory success, forecasting, and scenario analysis. This applies to both in-market and pipeline drugs, satisfying the future standard of care in each disease indication/segment. “BioXcel’s long-term commitment to developing PharmGPSTM has been supported by multiple clients working to meet patient needs,” said Dr. Krishnan Nandabalan, BioXcel’s President & CEO. “We are vigorously expanding current indications and commercializing this exciting new product to a wide biopharmaceutical audience.”

The platform is built on several years’ experience, deep domain expertise, commercially validated frameworks, and proprietary processes for generating insights and recommendations. The analytics engine operates on dynamic specialized data sets, each structured by experts from medical, clinical, scientific, commercial, and intellectual property disciplines. It also allows stakeholders to leverage intern
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
2. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
3. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
4. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
5. Neogen Launches Fully Quantitative Lateral Flow Test for DON
6. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
7. iHealth Lab Launches Personalized Web Portal to Store Your Vitals
8. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
9. Upsher-Smith Launches B-Nexa® Prescription Prenatal Vitamin With B Vitamins and Ginger for Nausea and Vomiting of Pregnancy
10. bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation
11. ERT Launches New Website to Support Significant Commercial Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... (Amex: ETC ) ("ETC" or the "Company") ... two BARA-MED(R) XD,Monoplace Hyperbaric Chambers at Christus Spohn, ... Christi, Texas, in 1905 and is,the largest and ... The,facility offers South Texans a full range of ...
... SAN DIEGO, Sept. 23 Halozyme Therapeutics,Inc. (Nasdaq: ... products targeting the extracellular matrix, today,announced that Douglas ... Vice,President, Endocrinology Clinical Development., "I am thrilled ... caliber,and achievement to the Halozyme leadership team. He ...
... Development of Novel Infectious ... Disease Diagnostic Platform -, WOBURN, ... a $4.5 million equity investment from BD (Becton, Dickinson,and Company) ... development of a novel infectious disease diagnostic,platform. The collaboration will ...
Cached Biology Technology:Environmental Tectonics Corporation Announces a Multiple Sale for Monoplace Hyperbaric Chambers 2Environmental Tectonics Corporation Announces a Multiple Sale for Monoplace Hyperbaric Chambers 3Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development 2Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development 3Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development 4U.S. Genomics Inc. Receives $4.5 Million Investment from BD 2U.S. Genomics Inc. Receives $4.5 Million Investment from BD 3
(Date:11/21/2014)... 2014   Atmel® Corporation (NASDAQ: ... touch technology solutions, today launched the industry,s first family ... widest V cc range from 1.7V to 5.5V. ... I 2 C bus communication speeds, and are available ... them ideal for consumer, industrial, computer, and medical applications. ...
(Date:11/18/2014)... , Nov. 18, 2014   EyeLock Inc. ... solutions, and MorphoTrust USA (Safran), a ... today announced a strategic partnership to offer comprehensive ... vehicle administration (MVA), airport screening and financial services ... solutions, MorphoTrust serves consumers through a nationwide network ...
(Date:11/10/2014)... store shelves in early 2010, and people have used ... can be tossed into a washing machine without ever ... convenience, though, has come with risks for young children. ... Hospital found that from 2012 through 2013, U.S. poison ... 6 years of age swallowing, inhaling, or otherwise being ...
Breaking Biology News(10 mins):Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Study finds laundry detergent pods, serious poisoning risk for children 2
... of ice, a minimally invasive interventional radiology treatment called ... damage, according to data being presented at the Society ... Orleans. "Cryoneurolysis could have big implications for the ... be unbearable and is very difficult to treat," said ...
... WEST ORANGE, N.J.The State of Spinal Cord Injury: Latest ... Recovery will be held on Wednesday, April 17, 2013, ... Pleasant Valley Way, West Orange, N.J. This special Grand ... Cord Injury System (NNJSCIS) and the Spinal Cord Injury ...
... have revealed the mechanism that causes a slime to ... antibiotics. When under threat, some bacteria can shield ... biofilm. It is made up of communities of bacteria ... cause dental plaque and sinusitis; in healthcare, biofilms can ...
Cached Biology News:Freezing nerves knocks pain out cold 2The State of Spinal Cord Injury Grand Rounds 2Secrets of bacterial slime revealed 2
384 Cluster Tube Racks...
The antibody recognizes the peptide sequence ESESQGPK (aa 441-448) of human class III beta-tubulin specific for neurones....
... Partially purified chicken intestinal cytoplasmic 1,25-(OH)2D3 ... receptor (VDR) from human, rat, mouse, ... This antibody does not cross-react ... MA1-710 detects both the occupied and ...
... compact, highly versatile power supply. Capable of producing ... power supply is ideal for PAGE, SDS-PAGE, DNA ... types of small format transfer apparatus. It is ... current with a continuously variable output in either ...
Biology Products: